IDEAYA Biosciences (IDYA) Interest Coverage Ratio (2018 - 2026)
IDEAYA Biosciences (IDYA) reported Interest Coverage Ratio of 0.89 for Q1 2026, up 89.92% on a YoY basis from 0.47 in Q1 2025, and up 99.91% sequentially from 945.7 in Q4 2025.
IDEAYA Biosciences (IDYA) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 9 years of Interest Coverage Ratio data on file, last reported at 0.89 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 89.92% year-over-year to 0.89; the trailing twelve-month figure through Mar 2026 stood at 1.51 (up 96.01% YoY), and the FY2025 full-year result was 0.81, up 59.1% from the prior year.
- Interest Coverage Ratio rose to 0.89 in Q1 2026, from 945.7 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 29.29 in Q4 2023 to a low of 1888.79 in Q4 2022.
- A 5-year average of 258.79 and a median of 1.91 in 2025 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio plunged 121473.87% in 2023 and soared 249.48% in 2025, its largest moves.
- Tracing IDYA's Interest Coverage Ratio over 5 years: stood at 1888.79 in 2022, then soared by 101.55% to 29.29 in 2023, then plunged by 5020.71% to 1441.38 in 2024, then surged by 34.39% to 945.7 in 2025, then surged by 99.91% to 0.89 in 2026.
- Business Quant data shows IDYA's Interest Coverage Ratio at 0.89 in Q1 2026, 945.7 in Q4 2025, and 1.38 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - | -0.89 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.89 |
| Dec 31, 2025 | -945.70 |
| Sep 30, 2025 | 1.38 |
| Jun 30, 2025 | -1.91 |
| Mar 31, 2025 | -8.86 |
| Dec 31, 2024 | -1,441.38 |
| Sep 30, 2024 | -0.92 |
| Jun 30, 2024 | -0.68 |
| Mar 31, 2024 | -49.24 |
| Dec 31, 2023 | 29.29 |
| Sep 30, 2023 | -43.37 |
| Jun 30, 2023 | -27.35 |
| Mar 31, 2023 | -17.93 |
| Dec 31, 2022 | -1,888.79 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | -1.54 |
| Mar 31, 2022 | -1.58 |
| Dec 31, 2021 | -9.96 |
| Sep 30, 2021 | -172.25 |
| Jun 30, 2021 | -690.69 |